Literature DB >> 28086005

Reducing Dropout in Treatment for Depression: Translating Dropout Predictors Into Individualized Treatment Recommendations.

Sigal Zilcha-Mano1,2, John R Keefe3, Harold Chui4, Avinadav Rubin2, Marna S Barrett5, Jacques P Barber4.   

Abstract

OBJECTIVE: Premature discontinuation of therapy is a widespread problem that hampers the delivery of mental health treatment. A high degree of variability has been found among rates of premature treatment discontinuation, suggesting that rates may differ depending on potential moderators. In the current study, our aim was to identify demographic and interpersonal variables that moderate the association between treatment assignment and dropout.
METHODS: Data from a randomized controlled trial conducted from November 2001 through June 2007 (N = 156) comparing supportive-expressive therapy, antidepressant medication, and placebo for the treatment of depression (based on DSM-IV criteria) were used. Twenty prerandomization variables were chosen based on previous literature. These variables were subjected to exploratory bootstrapped variable selection and included in the logistic regression models if they passed variable selection.
RESULTS: Three variables were found to moderate the association between treatment assignment and dropout: age, pretreatment therapeutic alliance expectations, and the presence of vindictive tendencies in interpersonal relationships. When patients were divided into those randomly assigned to their optimal treatment and those assigned to their least optimal treatment, dropout rates in the optimal treatment group (24.4%) were significantly lower than those in the least optimal treatment group (47.4%; P = .03).
CONCLUSIONS: Present findings suggest that a patient's age and pretreatment interpersonal characteristics predict the association between common depression treatments and dropout rate. If validated by further studies, these characteristics can assist in reducing dropout through targeted treatment assignment. TRIAL REGISTRATION: Secondary analysis of data from ClinicalTrials.gov identifier: NCT00043550. © Copyright 2016 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28086005     DOI: 10.4088/JCP.15m10081

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  6 in total

1.  A Machine Learning Approach to Identifying Placebo Responders in Late-Life Depression Trials.

Authors:  Sigal Zilcha-Mano; Steven P Roose; Patrick J Brown; Bret R Rutherford
Journal:  Am J Geriatr Psychiatry       Date:  2018-01-11       Impact factor: 4.105

2.  Personalized prescriptions of therapeutic skills from patient characteristics: An ecological momentary assessment approach.

Authors:  Christian A Webb; Marie Forgeard; Elana S Israel; Nathaniel Lovell-Smith; Courtney Beard; Thröstur Björgvinsson
Journal:  J Consult Clin Psychol       Date:  2021-04-08

3.  A prognostic index for long-term outcome after successful acute phase cognitive therapy and interpersonal psychotherapy for major depressive disorder.

Authors:  Suzanne C van Bronswijk; Lotte H J M Lemmens; John R Keefe; Marcus J H Huibers; Robert J DeRubeis; Frenk P M L Peeters
Journal:  Depress Anxiety       Date:  2018-12-05       Impact factor: 6.505

4.  Psychotherapy or medication for depression? Using individual symptom meta-analyses to derive a Symptom-Oriented Therapy (SOrT) metric for a personalised psychiatry.

Authors:  Nils Kappelmann; Martin Rein; Julia Fietz; Helen S Mayberg; W Edward Craighead; Boadie W Dunlop; Charles B Nemeroff; Martin Keller; Daniel N Klein; Bruce A Arnow; Nusrat Husain; Robin B Jarrett; Jeffrey R Vittengl; Marco Menchetti; Gordon Parker; Jacques P Barber; Andre G Bastos; Jack Dekker; Jaap Peen; Martin E Keck; Johannes Kopf-Beck
Journal:  BMC Med       Date:  2020-06-05       Impact factor: 8.775

5.  Dropping out of a transdiagnostic online intervention: A qualitative analysis of client's experiences.

Authors:  J Fernández-Álvarez; A Díaz-García; A González-Robles; R Baños; A García-Palacios; C Botella
Journal:  Internet Interv       Date:  2017-09-22

6.  Precision medicine for long-term depression outcomes using the Personalized Advantage Index approach: cognitive therapy or interpersonal psychotherapy?

Authors:  Suzanne C van Bronswijk; Robert J DeRubeis; Lotte H J M Lemmens; Frenk P M L Peeters; John R Keefe; Zachary D Cohen; Marcus J H Huibers
Journal:  Psychol Med       Date:  2019-11-22       Impact factor: 7.723

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.